Searchable abstracts of presentations at key conferences in endocrinology

ea0031p150 | Neoplasia, cancer and late effects | SFEBES2013

POMC correlates with viable tumour cell mass in lung cancer xenografts

Bryant Jennifer

Small cell lung cancer (SCLC) is the most common cause of the ectopic ACTH syndrome and is characterised by rapid growth and poor prognosis. In the ectopic ACTH syndrome, tumours secrete highly elevated levels of the ACTH precursor, proopiomelanocortin (POMC), compared to ACTH itself (Oliver 2003). This study aimed to develop a mouse model of SCLC capable of secreting high levels of POMC and correlate this with viable tumour mass to assess POMC as a potential biomarker.<p ...

ea0080OC3 | Oral Communications | UKINETS2021

An update on the effects of debulking surgery and liver directed intra-arterial therapies on quality of life in patients with metastatic neuroendocrine tumours

Woods Eleanor , Sinclair Adam , Jarvis Emma , Ramsey Emma , Tanno Lulu , Naheed Salma , Armstrong Thomas , Takhar Arjun , Knight John , Stedman Brian , Modi Sachin , Bryant Timothy , Breen David , Nolan Luke , Al-Mrayat Ma'en , Pearce Neil , Cave Judith

Background: Neuroendocrine tumours (NETs) arise from neuroendocrine cells, they are commonly found in the pancreas, small bowel and lung. They are a heterogeneous group of tumours capable of secreting a variety of hormones, therefore the spectrum of symptoms is broad. Treatment options for metastatic NETs include cytoreductive surgery, or interventional radiology procedures such as transarterial embolization (TAE). Aims: Previous studies have shown that ...

ea0010p75 | Steroids to include Cushing's | SFE2005

Effect of meal fat content on salivary testosterone and cortisol levels in healthy female volunteers

Al-Dujaili E , Bryant M

The aim of this study was to determine if a change in the amount of fat consumed in the diet influenced female salivary postprandial testosterone and cortisol concentrations and whether any changes affected circadian rhythm.The study was conducted on 9 healthy female subjects aged 21–45 years (BMI mean=22.5±1.61) and has been approved by the University College Ethical Committee. Over 3 non-consecutive days, each subject consumed 2 meals, lunch...

ea0010oc24 | Young Endocrinologist session | SFE2005

Bovine endometrial cells express toll-like receptor 4 (TLR4) and secrete prostaglandins in response to lipopolysaccharide

Herath S , Bryant|I##Sheldon C

Corpus luteum lifespan is regulated by the secretion of prostaglandins (PGF and PGE) from the endometrium. which are synthesized by cyclo-oxygenase 2 (COX-2). However. corpus luteum lifespan is altered by uterine bacterial infections. causing infertility. Uterine infection is common after parturition in cattle. often involving Escherichia coli. The pathogenic ligand of E. coli. lipopolysaccharide (LPS). is detected by Toll-like Receptor 4 (TLR4). predominantly fo...

ea0073ep88 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Rooibos tea (Aspalathus linearis) upregulates hepatic sex hormone-binding globulin production

Laura Briansó Llort , Pheiffer Carmen , Fuertes Rioja Lidia , Ramos Perez Lorena , Hernandez Cristina , Simo Canonge Rafael , Martinez David

Sex hormone-binding globulin (SHBG) is a circulating plasma glycoprotein produced by the liver, which in the blood binds estrogens and androgens with high affinity and regulates its bioavailability. Low plasma SHBG levels are associated with obesity, metabolic syndrome and non-alcoholic fatty liver disease. Importantly, epidemiological studies have demonstrated that low plasma SHBG levels is a risk factor for developing type 2 diabetes and cardiovascular disease. In the last y...

ea0022p17 | Adrenal | ECE2010

Salivary cortisol in the diagnosis of Cushing's syndrome: clinical experience with liquid chromatography/tandem mass spectrometry on outpatient basis

Erickson Dana , Singh Ravinder , Sathananthan Airani , Vella Adrian , Bryant Sandra

Late night salivary cortisol measurements have been increasingly used as an initial diagnostic test for the evaluation of patients with a clinical suspicion of Cushing syndrome (CS). Published studies include varying numbers of cases and controls and importantly various assay methods (usually immunoassays), as well as various methods of generating normative values.Materials and methods: We examined the diagnostic utility of salivary cortisol measurement ...

ea0034p171 | Neoplasia, cancer and late effects | SFEBES2014

Neuroendocrine biomarkers change with treatment in small cell lung cancer

Meredith Suzanne , Bryant Jennifer , Babur Muhammad , Riddell Philip , Williams Kaye , White Anne

Small cell lung cancer (SCLC) is distinguished by its neuroendocrine phenotype and secretion of hormone biomarkers. Tumours initially respond well to therapy but almost invariably relapse with a therapy-resistant phenotype. We have previously described pro-opiomelanocortin (POMC) as a potential biomarker of SCLC. In this study, we investigated how POMC acts as a biomarker of tumour response to treatment.SCLC cells (DMS 79) were injected subcutaneously in...

ea0068p23 | Abstracts | UKINETS2019

Effects of debulking surgery, transarterial embolisation (TAE) and transarterial chemoembolisation (TACE) on quality of life in patients with metastatic ileal and pancreatic neuroendocrine tumours (NETs)

Sinclair Adam , Tanno Lulu , Jarvis Emma , Ramsey Emma , Naheed Salma , Armstrong Thomas , Takhar Arjun , Knight John , Stedman Brian , Modi Sachin , Bryant Timothy , Breen David , Nolan Luke , Al-Mrayat Ma'en , Pearce Neil , Cave Judith

Neuroendocrine tumours (NETs) are a heterogenous group of tumours that arise from neuroendocrine cells throughout the body. Debulking surgery is offered to patients with metastatic NETs and is recommended in the ENETS guidelines. This study was undertaken to evaluate the impact of debulking surgery and liver directed therapy (TACE, TAE) in metastatic NETs, on quality of life (QoL). Prospective longitudinal cohort study was undertaken at University Hospital Southampton. Patient...

ea0077oc2.5 | Endocrine Cancer and Late Effects | SFEBES2021

A novel MiR-346-Directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer

Fletcher Claire , Orafidiya Folake , Deng Lin , Yuan Wei , Lorentzen Marc , Cyran Oliwia , Varela-Carver Anabel , Constantin Theodora , Dobbs Felix , Figueiredo Ines , Gurel Bora , Parkes Eileen , Bogdan Denisa , Pereira Ronnie , Zhao Shuang (George) , Neeb Antje , Issa Fadi , Hester Joanna , Kudo Hiromi , Liu Yang , Philippou Yiannis , Bristow Robert , Knudsen Karen , Bryant Richard , Feng Felix , Reed Simon , Mills Ian , de Bono Johann , Bevan Charlotte

MiR-346 is an Androgen Receptor (AR)-activating miR that associates with DNA damage response (DDR)-linked transcripts in prostate cancer (PC). MiR-346 induces rapid and extensive DNA damage in PC cells through chromatin association, activation of transcription, R-loop formation and DNA replication stress, leading to checkpoint activation and cell cycle arrest. MiR-346 interacts with lncRNA, NORAD, in PC cells, which functions to maintain mitosis, DDR, and chromosomal integrity...

ea0090p29 | Calcium and Bone | ECE2023

TransCon PTH Improves Health-Related Quality of Life and Reduces Work Limitations in Adults With Hypoparathyroidism: Patient-Reported Outcomes in the Phase 3 PaTHway Trial

Palermo Andrea , Khan Aliya , Rubin Mishaela , Schwarz Peter , Shoback Dolores M. , Gagnon Claudia , Cetani Filomena , Clarke Bart L. , Tsourdi Elena , Kohlmeier Lynn , Sikjaer Tanja , M Kaiser Stephanie , Lai Bryant , Le John , Ukena Jenny , Sibley Christopher , Shu Aimee , An Xubei , Noori Wahidullah , Smith Alden , Vokes Tamara J.

Background: Individuals with hypoparathyroidism often experience a range of symptoms associated with reduced health-related quality of life (HRQoL) and work productivity. Conventional therapy aims to alleviate hypocalcemia and acute symptoms but fails to restore normal parathyroid hormone (PTH) physiology or improve HRQoL. In the PaTHway trial, 79% of participants treated with TransCon PTH vs. 5% placebo (P<0.0001) met the primary efficacy endpoint (normal serum c...